Pricing
In 2019 Prof Andrew Tobin published validation of PfCLK3 as a target with breakthrough potential in the treatment of malaria. Successful drug development would provide a single medicine that is curative, transmission blocking and prophylactic.
Headquarters
Employees
Links
Org chart
Teams
Offices
Positions (3)
Unverified
This company has no teams yet
This company has no offices yet